NCT03934957 Hamburg City Health Study - a German Cohort Study
| NCT ID | NCT03934957 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universitätsklinikum Hamburg-Eppendorf |
| Condition | Coronary Heart Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 45,000 participants |
| Start Date | 2016-02-08 |
| Primary Completion | 2022-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 45,000 participants in total. It began in 2016-02-08 with a primary completion date of 2022-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Hamburg City Health Study (HCHS) is a large, prospective, long-term, population-based cohort study and a unique research platform and network to obtain substantial knowledge about several risk and prognostic factors in major chronic diseases.
Eligibility Criteria
Inclusion Criteria: * Inhabitant of the city of Hamburg at the time of inclusion into the study (Inclusion is time of written consent) * Age 45 to 74 years * Personally signed informed consent Exclusion Criteria: * Insufficient knowledge of the German language, in order to understand study documents and computer assisted interview without translation * Physical or psychological incapability to travel to the study center and to cooperate in the investigations
Contact & Investigator
Stefan Blankenberg, Professor
PRINCIPAL INVESTIGATOR
Universitäres Herzzentrum Hamburg
Frequently Asked Questions
Who can join the NCT03934957 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, up to 74 Years, studying Coronary Heart Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03934957 currently recruiting?
Yes, NCT03934957 is actively recruiting participants. Contact the research team at A.Jagodzinski@uke.de for enrollment information.
Where is the NCT03934957 trial being conducted?
This trial is being conducted at Hamburg, Germany.
Who is sponsoring the NCT03934957 clinical trial?
NCT03934957 is sponsored by Universitätsklinikum Hamburg-Eppendorf. The principal investigator is Stefan Blankenberg, Professor at Universitäres Herzzentrum Hamburg. The trial plans to enroll 45,000 participants.